A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension

• Status: Completed
• Trial end date: 2013-11-01

Summary

The purpose of this study is to evaluate the antihypertensive efficacy and safety of Fimasartan

• Phase: Phase 2

Details

• Lead Sponsor: Boryung Pharmaceutical Co., Ltd
• Collaborators: Asan Medical Center; Busan National University Yangsan Hospital; Catholic University of Korea Saint Paul's Hospital; Cheil General Hospital and Women's Healthcare Center; Cheil General Hospital and Women’s Healthcare Center; Chonnam National University Hospital; Chungnam National University; Daegu Catholic University Medical Center; DongGuk University; Gachon University Gil Medical Center; Hallym University Kangnam Sacred Heart Hospital; Hanyang University Seoul Hospital; Inha University Hospital; Inje University; Jeju National University Hospital; Kangbuk Samsung Hospital; Korea University Guro Hospital; Kyungpook National University; Kyungpook National University Hospital; Samsung Medical Center; Seoul National University Bundang Hospital; Seoul National University Hospital; Soon Chun Hyang University; The Catholic University of Korea; Wonju Severance Christian Hospital; Wonkwang University Hospital; Yeungnam University; Yeungnam University Hospital
• Treatments: Amlodipine